Literature DB >> 18370617

Psychopathy as a clinical and empirical construct.

Robert D Hare1, Craig S Neumann.   

Abstract

In this review, we focus on two major influences on current conceptualizations of psychopathy: one clinical, with its origins largely in the early case studies of Cleckley, and the other empirical, the result of widespread use of the Hare Psychopathy Checklist-Revised (PCL-R) for assessment purposes. Some investigators assert that the PCL-R, ostensibly based on Cleckley's work, has "drifted" from the construct described in his Clinical Profile. We evaluate this profile, note its basis in an unrepresentative sample of patients, and suggest that its literal and uncritical acceptance by the research community has become problematical. We also argue that the idea of construct "drift" is irrelevant to current conceptualizations of psychopathy, which are better informed by the extensive empirical research on the integration of structural, genetic, developmental, personality, and neurobiological research findings than by rigid adherence to early clinical formulations. We offer some suggestions for future research on psychopathy.

Entities:  

Mesh:

Year:  2008        PMID: 18370617     DOI: 10.1146/annurev.clinpsy.3.022806.091452

Source DB:  PubMed          Journal:  Annu Rev Clin Psychol        ISSN: 1548-5943            Impact factor:   18.561


  144 in total

1.  Factor structure of the Hare Psychopathy Checklist: Youth Version (PCL:YV) in adolescent females.

Authors:  David S Kosson; Craig S Neumann; Adelle E Forth; Randall T Salekin; Robert D Hare; Maya K Krischer; Kathrin Sevecke
Journal:  Psychol Assess       Date:  2012-06-25

Review 2.  Evolutionary causes and consequences of consistent individual variation in cooperative behaviour.

Authors:  Ralph Bergmüller; Roger Schürch; Ian M Hamilton
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-09-12       Impact factor: 6.237

3.  The neural signatures of distinct psychopathic traits.

Authors:  Justin M Carré; Luke W Hyde; Craig S Neumann; Essi Viding; Ahmad R Hariri
Journal:  Soc Neurosci       Date:  2012-07-09       Impact factor: 2.083

4.  Are fearless dominance traits superfluous in operationalizing psychopathy? Incremental validity and sex differences.

Authors:  Brett Murphy; Scott Lilienfeld; Jennifer Skeem; John F Edens
Journal:  Psychol Assess       Date:  2016-02-11

5.  Aggression, impulsivity, and psychopathic traits in combined antisocial personality disorder and substance use disorder.

Authors:  Joseph L Alcorn; Joshua L Gowin; Charles E Green; Alan C Swann; F Gerard Moeller; Scott D Lane
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2013       Impact factor: 2.198

6.  Using latent variable- and person-centered approaches to examine the role of psychopathic traits in sex offenders.

Authors:  Sonja Krstic; Craig S Neumann; Sandeep Roy; Carrie A Robertson; Raymond A Knight; Robert D Hare
Journal:  Personal Disord       Date:  2017-04-13

7.  Primary and Secondary Variants of Psychopathy in a Volunteer Sample Are Associated With Different Neurocognitive Mechanisms.

Authors:  Arjun Sethi; Eamon McCrory; Vanessa Puetz; Ferdinand Hoffmann; Annchen R Knodt; Spenser R Radtke; Bartholomew D Brigidi; Ahmad R Hariri; Essi Viding
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-04-12

8.  Unmasking the Association between Psychopathic Traits and Adaptive Functioning in Children.

Authors:  Joshua Isen; Laura Baker; Melissa Kern; Adrian Raine; Serena Bezdjian
Journal:  Pers Individ Dif       Date:  2017-12-22

9.  Response monitoring and adjustment: differential relations with psychopathic traits.

Authors:  Konrad Bresin; M Sima Finy; Jenessa Sprague; Edelyn Verona
Journal:  J Abnorm Psychol       Date:  2014-06-16

10.  Unique and Interactive Associations Between Maltreatment and Complex Emotion Recognition Deficits and Psychopathic Traits in an Undergraduate Sample.

Authors:  Rebecca Waller; Hannah K McCabe; Hailey L Dotterer; Craig S Neumann; Luke W Hyde
Journal:  J Pers Disord       Date:  2017-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.